Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 37% ± 24% | |
endothelial cell | 6 studies | 31% ± 13% | |
retinal cone cell | 6 studies | 28% ± 7% | |
GABAergic neuron | 6 studies | 39% ± 22% | |
oligodendrocyte | 6 studies | 21% ± 6% | |
interneuron | 5 studies | 35% ± 21% | |
oligodendrocyte precursor cell | 5 studies | 27% ± 9% | |
astrocyte | 5 studies | 28% ± 10% | |
neuron | 4 studies | 26% ± 11% | |
granule cell | 4 studies | 24% ± 2% | |
epithelial cell | 3 studies | 27% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 31% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4062.41 | 1445 / 1445 | 100% | 17.93 | 183 / 183 |
skin | 100% | 4710.70 | 1807 / 1809 | 99% | 10.50 | 467 / 472 |
brain | 99% | 5540.73 | 2616 / 2642 | 99% | 11.04 | 701 / 705 |
thymus | 100% | 4531.42 | 653 / 653 | 98% | 7.86 | 590 / 605 |
breast | 100% | 2598.78 | 458 / 459 | 96% | 6.71 | 1075 / 1118 |
stomach | 100% | 2192.52 | 359 / 359 | 95% | 5.54 | 273 / 286 |
uterus | 100% | 3391.66 | 170 / 170 | 95% | 9.20 | 437 / 459 |
lung | 99% | 1921.35 | 574 / 578 | 95% | 8.00 | 1096 / 1155 |
kidney | 100% | 1842.54 | 89 / 89 | 92% | 5.17 | 829 / 901 |
bladder | 100% | 3587.00 | 21 / 21 | 92% | 5.53 | 463 / 504 |
prostate | 100% | 2851.94 | 245 / 245 | 91% | 4.83 | 456 / 502 |
adrenal gland | 100% | 2938.82 | 258 / 258 | 90% | 5.01 | 207 / 230 |
intestine | 100% | 2464.82 | 963 / 966 | 89% | 4.28 | 470 / 527 |
ovary | 100% | 4352.73 | 180 / 180 | 86% | 4.73 | 370 / 430 |
pancreas | 85% | 875.37 | 278 / 328 | 96% | 5.30 | 171 / 178 |
spleen | 100% | 2384.04 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.46 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.69 | 1 / 1 |
blood vessel | 100% | 2351.45 | 1331 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1884.07 | 1200 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 7.24 | 77 / 80 |
liver | 50% | 428.96 | 112 / 226 | 40% | 1.41 | 164 / 406 |
heart | 88% | 1148.72 | 759 / 861 | 0% | 0 | 0 / 0 |
muscle | 78% | 788.51 | 630 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 3.46 | 20 / 29 |
peripheral blood | 47% | 744.51 | 433 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1900425 | Biological process | negative regulation of defense response to bacterium |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0032717 | Biological process | negative regulation of interleukin-8 production |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0005730 | Cellular component | nucleolus |
GO_0097431 | Cellular component | mitotic spindle pole |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | MAPKBP1 |
Protein name | Mitogen-activated protein kinase-binding protein 1 (JNK-binding protein 1) (JNKBP-1) Alternative protein MAPKBP1 Mitogen-activated protein kinase binding protein 1 |
Synonyms | JNKBP1 KIAA0596 |
Description | FUNCTION: Negative regulator of NOD2 function. It down-regulates NOD2-induced processes such as activation of NF-kappa-B signaling, IL8 secretion and antibacterial response . Involved in JNK signaling pathway (By similarity). . |
Accessions | ENST00000627631.1 ENST00000514566.5 [O60336-2] ENST00000457542.7 [O60336-6] ENST00000512970.5 ENST00000456763.6 [O60336-1] D6R9F7 D6RHX7 L8E7J2 O60336 D6RAI2 ENST00000510535.1 ENST00000505373.5 |